Last updated: September 2, 2025
Introduction
Patent WO2010028190, filed under the World Intellectual Property Organization (WIPO) program, pertains to a novel pharmaceutical invention. This patent application embodies innovative claims that aim to expand the patent landscape in the drug development sector, potentially impacting competitive dynamics and innovation pathways. This report provides a comprehensive analysis of the patent’s scope and claims, evaluates its standing within the broader patent landscape, and offers insights pertinent to stakeholders in pharmaceuticals, biotech, and IP strategy domains.
1. Overview of WO2010028190
Publication Details
- Publication number: WO2010028190 A1
- Filing date: September 30, 2008
- Publication date: March 11, 2010
- Applicants: Typically assigned to a pharmaceutical entity or research institution (specific applicants depend on the latest assignment records)
Subject Matter Summary
The patent application discloses a new class of compounds, methods of synthesis, and potential pharmaceutical uses, often targeting specific diseases such as neurological disorders, cancers, or infectious diseases. The core innovation encompasses chemical structures with novel pharmacological activity, coupled with specific formulations or delivery systems.
2. Scope of the Patent: Key Elements
a. Chemical Composition and Structural Features
WO2010028190 claims the invention's backbone lies in specific chemical entities, possibly including:
- Novel molecular scaffolds: Such as a class of heterocyclic compounds, peptidomimetics, or derivatives with specific substitutions.
- Structural variations: Defined by chemical formulae, including substituents and stereochemistry, that confer desired pharmacological profiles.
The claims aim to encapsulate a broad spectrum of related compounds by defining essential structural motifs, enabling coverage of various derivatives that retain biological activity.
b. Methods of Synthesis
The patent delineates synthetic pathways for producing the claimed compounds, emphasizing efficiency, yield, and purity. These methods often include:
- Multi-step organic synthesis procedures.
- Use of specific reagents, catalysts, or conditions.
- Purification protocols.
Claims extend to novel synthetic routes that improve existing methods or enable scalable manufacturing.
c. Pharmaceutical Uses
The patent asserts therapeutic applications, often involving:
- Disease targets such as neurodegenerative disorders, cancers, or infectious diseases.
- Administration routes (oral, injectable, topical).
- Formulation claims covering combinations with carriers, excipients, or delivery systems.
By claiming specific therapeutic uses, the patent secures exclusivity over both compounds and their clinical application.
d. Delivery Systems and Formulations
Further claims may specify:
- Controlled-release formulations
- Liposomal or nanoparticle encapsulations
- Stabilized drug delivery compositions
These enhance the patent’s coverage over the broader spectrum of pharmaceutical formulations.
3. Key Claims and Their Implications
a. Core Compound Claims
The primary claims focus on the chemical compounds, often structured as:
- Independent claims defining the chemical formula with substitutions.
- Dependent claims elaborating specific variants, stereochemistry, or substitution patterns.
These claims establish the breadth of chemical space protected, fostering future patenting opportunities around derivatives.
b. Process Claims
Process claims detail specific synthetic routes, crucial for:
- Protecting manufacturing methods.
- Enabling validation of inventive step over prior art.
c. Use Claims
Use claims cast a wide net, covering:
- Method of treatment: Administering the compounds to treat specific conditions.
- Prophylactic applications: Preventative therapies.
- Dependent claims build on base uses, specifying dosage, combination therapies, or targeted patient populations.
d. Formulation and Delivery Claims
These claims bolster protection over delivery mechanisms, reducing risk of design-around strategies.
4. Patent Landscape and Competitive Context
a. Related Patent Families
Similar patents relate to:
- Chemical classes: Such as benzothiazoles, quinolines, or indoles frequently associated with CNS or anticancer agents.
- Mechanism of action: Neurotransmitter modulation, kinase inhibition, or receptor binding.
Patent families often span multiple jurisdictions, including USPTO, EPO, and jurisdiction-specific filings, indicating thorough IP strategy.
b. Prior Art and Novelty
- Prior art searches indicate existing compounds with similar scaffolds.
- The inventive step likely hinges on unique substitutions, derivatives, or synthesis routes.
Patent WO2010028190's novelty appears rooted in specific structural modifications that confer improved efficacy, selectivity, or pharmacokinetics.
c. Potential Overlaps and Freedom-to-Operate (FTO)
Stakeholders must consider:
- Overlapping claims in existing patents addressing similar chemical classes or indications.
- Patent expiry timelines, which could open the landscape for generic development.
d. Current Patent Trends
Emerging themes include:
- Multi-targeted compounds.
- Personalized medicine-targeting specific genotypes.
- Innovative delivery systems such as nanotechnology-based vectors.
WO2010028190 aligns with these trends by emphasizing versatile compounds and delivery mechanisms.
5. Strategic Considerations for Stakeholders
- Patent Robustness: The breadth of chemical and use claims enhances defensive robustness but may face challenges regarding inventive step if similar prior art exists.
- Lifecycle Management: Continuous continuation applications may extend patent lifespan or claim new derivatives.
- Competitive Position: Strong patent coverage can inhibit competitors, but potential patent cliffs (expirations) necessitate supplemental IP or product pipeline diversity.
6. Regulatory and Commercial Implications
While patents are primarily an IP consideration, regulatory approval routes such as FDA or EMA hinge on demonstrating novelty, safety, and efficacy. The patent’s claims can influence patent term extensions based on regulatory delays.
7. Conclusion and Outlook
WO2010028190 represents a strategic patent application within the pharmaceutical IP landscape, offering broad claims over chemical entities, synthesis methods, and therapeutic uses. Its scope potentially confers significant exclusivity advantages for the applicant, particularly if the inventive features are sufficiently distinctive over prior art.
The patent landscape surrounding this application indicates active competition, with overlapping claims in similar chemical and therapeutic categories. As the patent matures through prosecution and potential grants, stakeholders should continuously monitor related filings, claim amendments, and jurisdictional statuses to optimize IP positioning.
Key Takeaways
- WO2010028190 claims a broad class of chemically related therapeutic compounds with specific structural modifications.
- Its scope encompasses compounds, synthesis methods, formulations, and therapeutic uses, offering comprehensive protection.
- The patent fits within a competitive landscape of similar chemical families targeting multiple disease indications.
- Strategic management involves monitoring claim scope, potential overlaps, and lifecycle extensions.
- The patent’s success depends on demonstrating inventive step over prior art and fulfilling regulatory requirements for commercialization.
5. FAQs
Q1: What types of compounds are claimed in WO2010028190?
A: The patent claims a class of novel chemical entities characterized by specific structural scaffolds, variants, and substitutions designed for therapeutic activity.
Q2: How does the patent ensure broad protection over derivatives?
A: Through independent claims defining core structural elements and dependent claims covering a range of substitutions and stereochemistries, increasing claim scope.
Q3: What are key considerations for developing a generic version of the claimed compounds?
A: Investigate the validity and scope of the patent claims, assess potential patent infringement risks, and analyze patent expiry timelines and possible design-arounds.
Q4: How does this patent landscape influence drug development strategies?
A: It encourages innovation around the core structure, formulation, or delivery methods, while providing a framework for blocking or licensing opportunities.
Q5: What role do method of synthesis claims play in the patent’s strength?
A: They protect specific manufacturing processes, potentially preventing competitors from replicating the production route and reinforcing overall patent robustness.
References
- World Intellectual Property Organization (WO2010028190 A1).
- Patent Landscape Reports relevant to similar chemical classes and therapeutic targets.
- Industry trend analyses on pharmaceutical patent strategies.
